A Multicenter, Randomized, Double-blind Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab) for the Treatment of Patients With Psoriatic Arthritis
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010135/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine if Infliximab is safe and effective in the
treatment of psoriatic arthritis. Infliximab (Remicade) targets specific proteins in the
body's immune system to help control the development of inflammation to help reduce painful
disease.
提供机构：
Vivli
创建时间：
2024-05-28
